Bio-Rad Laboratories (NYSE:BIO.B) Hits New 12-Month High – Here’s What Happened

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) hit a new 52-week high on Monday. The company traded as high as $389.98 and last traded at $389.98, with a volume of 76 shares. The stock had previously closed at $379.50.

Bio-Rad Laboratories Stock Performance

The firm has a market capitalization of $10.43 billion, a price-to-earnings ratio of 10.27 and a beta of 1.00. The company has a fifty day moving average of $368.50 and a two-hundred day moving average of $313.76. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.37 and a current ratio of 3.18.

Bio-Rad Laboratories (NYSE:BIO.B) last released its quarterly earnings results on Wednesday, November 4th. The company reported $2.65 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a return on equity of 3.58% and a net margin of 39.45%. The business had revenue of $656.40 million during the quarter.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. develops and manufactures products for life science research and clinical diagnostics. Founded in 1952, the company serves research institutions, biotechnology and pharmaceutical companies, clinical laboratories, hospitals and other customers around the world. Its life science business supplies instruments, reagents and software used in areas such as gene expression, protein analysis, cell biology and genomics. Its offerings include PCR and digital PCR systems, electrophoresis products and tools for protein purification and analysis.